Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Peter Henson to Platelet Activating Factor

This is a "connection" page, showing publications Peter Henson has written about Platelet Activating Factor.

 
Connection Strength
  
 
 
1.803
  
  1. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998 Feb 15; 101(4):890-8.
    View in: PubMed
    Score: 0.148
  2. Rose DM, Fadok VA, Riches DW, Clay KL, Henson PM. Autocrine/paracrine involvement of platelet-activating factor and transforming growth factor-beta in the induction of phosphatidylserine recognition by murine macrophages. J Immunol. 1995 Dec 15; 155(12):5819-25.
    View in: PubMed
    Score: 0.127
  3. Henson PM, Barnes PJ, Banks-Schlegel SP. NHLBI workshop summary. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. Am Rev Respir Dis. 1992 Mar; 145(3):726-31.
    View in: PubMed
    Score: 0.098
  4. Bratton DL, Dreyer E, Kailey JM, Fadok VA, Clay KL, Henson PM. The mechanism of internalization of platelet-activating factor in activated human neutrophils. Enhanced transbilayer movement across the plasma membrane. J Immunol. 1992 Jan 15; 148(2):514-23.
    View in: PubMed
    Score: 0.097
  5. Bratton DL, Kailey JM, Clay KL, Henson PM. A model for the extracellular release of PAF: the influence of plasma membrane phospholipid asymmetry. Biochim Biophys Acta. 1991 Feb 11; 1062(1):24-34.
    View in: PubMed
    Score: 0.091
  6. Accurso FJ, Abman SH, Wilkening RB, Worthen GS, Henson P. Fetal pulmonary vasodilation after exogenous platelet-activating factor. J Appl Physiol (1985). 1991 Feb; 70(2):778-87.
    View in: PubMed
    Score: 0.091
  7. Riches DW, Young SK, Seccombe JF, Henson JE, Clay KL, Henson PM. The subcellular distribution of platelet-activating factor in stimulated human neutrophils. J Immunol. 1990 Nov 01; 145(9):3062-70.
    View in: PubMed
    Score: 0.089
  8. Clay KL, Johnson C, Henson P. Binding of platelet activating factor to albumin. Biochim Biophys Acta. 1990 Oct 01; 1046(3):309-14.
    View in: PubMed
    Score: 0.089
  9. Henson PM. Bioassay of platelet-activating factor by release of [3H]serotonin. Methods Enzymol. 1990; 187:130-4.
    View in: PubMed
    Score: 0.084
  10. Henson PM. PAF--a perspective. Am J Respir Cell Mol Biol. 1989 Oct; 1(4):263-5.
    View in: PubMed
    Score: 0.083
  11. Bethel RA, Curtis SP, Lien DC, Irvin CG, Worthen GS, Leff AR, Henson PM. Effect of PAF on parasympathetic contraction of canine airways. J Appl Physiol (1985). 1989 Jun; 66(6):2629-34.
    View in: PubMed
    Score: 0.081
  12. Bratton DL, Harris RA, Clay KL, Henson PM. Effects of platelet activating factor on calcium-lipid interactions and lateral phase separations in phospholipid vesicles. Biochim Biophys Acta. 1988 Aug 18; 943(2):211-9.
    View in: PubMed
    Score: 0.076
  13. Bratton DL, Harris RA, Clay KL, Henson PM. Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. Biochim Biophys Acta. 1988 Jun 07; 941(1):76-82.
    View in: PubMed
    Score: 0.075
  14. Kimani G, Tonnesen MG, Henson PM. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. J Immunol. 1988 May 01; 140(9):3161-6.
    View in: PubMed
    Score: 0.075
  15. Lynch JM, Henson PM. The intracellular retention of newly synthesized platelet-activating factor. J Immunol. 1986 Oct 15; 137(8):2653-61.
    View in: PubMed
    Score: 0.067
  16. Voelkel NF, Chang SW, Pfeffer KD, Worthen SG, McMurtry IF, Henson PM. PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung. Prostaglandins. 1986 Sep; 32(3):359-72.
    View in: PubMed
    Score: 0.067
  17. Clay KL, Murphy RC, Andres JL, Lynch J, Henson PM. Structure elucidation of platelet activating factor derived from human neutrophils. Biochem Biophys Res Commun. 1984 Jun 29; 121(3):815-25.
    View in: PubMed
    Score: 0.057
  18. Worthen GS, Goins AJ, Mitchel BC, Larsen GL, Reeves JR, Henson PM. Platelet-activating factor causes neutrophil accumulation and edema in rabbit lungs. Chest. 1983 May; 83(5 Suppl):13S-15S.
    View in: PubMed
    Score: 0.053
  19. Nieminen MM, Henson PM, Irvin CG. Bimodal effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit. Exp Lung Res. 1994 Nov-Dec; 20(6):559-77.
    View in: PubMed
    Score: 0.029
  20. Bethel RA, Worthen GS, Henson PM, Lien DC. Effects of neutrophil depletion and repletion on PAF-induced hyperresponsiveness of canine trachea. J Appl Physiol (1985). 1992 Dec; 73(6):2413-9.
    View in: PubMed
    Score: 0.026
  21. Lien DC, Worthen GS, Henson PM, Bethel RA. Platelet-activating factor causes neutrophil accumulation and neutrophil-mediated increased vascular permeability in canine trachea. Am Rev Respir Dis. 1992 Mar; 145(3):693-700.
    View in: PubMed
    Score: 0.024
  22. Fradin A, Zirrolli JA, Maclouf J, Vausbinder L, Henson PM, Murphy RC. Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism. J Immunol. 1989 Dec 01; 143(11):3680-5.
    View in: PubMed
    Score: 0.021
  23. Berry KA, Henson PM, Murphy RC. Effects of acrolein on leukotriene biosynthesis in human neutrophils. Chem Res Toxicol. 2008 Dec; 21(12):2424-32.
    View in: PubMed
    Score: 0.020
  24. Stenmark KR, Eyzaguirre M, Westcott JY, Henson PM, Murphy RC. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. Am Rev Respir Dis. 1987 Sep; 136(3):770-2.
    View in: PubMed
    Score: 0.018
  25. Haroldsen PE, Voelkel NF, Henson JE, Henson PM, Murphy RC. Metabolism of platelet-activating factor in isolated perfused rat lung. J Clin Invest. 1987 Jun; 79(6):1860-7.
    View in: PubMed
    Score: 0.018
  26. Chang SW, Feddersen CO, Henson PM, Voelkel NF. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest. 1987 May; 79(5):1498-509.
    View in: PubMed
    Score: 0.017
  27. Voelkel NF, Simpson J, Worthen S, Reeves JT, Henson PM, Murphy RC. Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. Adv Prostaglandin Thromboxane Leukot Res. 1983; 12:179-83.
    View in: PubMed
    Score: 0.013
  28. Larsen GL, Henson PM. Mediators of inflammation. Annu Rev Immunol. 1983; 1:335-59.
    View in: PubMed
    Score: 0.013
  29. Voelkel NF, Worthen S, Reeves JT, Henson PM, Murphy RC. Nonimmunological production of leukotrienes induced by platelet-activating factor. Science. 1982 Oct 15; 218(4569):286-9.
    View in: PubMed
    Score: 0.013
  30. Henson PM. Platelet-activating factor (PAF) as a mediator of neutrophil-platelet interactions in inflammation. Agents Actions. 1981 Dec; 11(6-7):545-7.
    View in: PubMed
    Score: 0.012
  31. Henson PM, Betz SJ. Neutrophil and platelet interactions in "allergic" and inflammatory reactions: a role for acetyl glyceryl ether phosphorylcholine (platelet-activating factor). Kroc Found Ser. 1981; 14:51-66.
    View in: PubMed
    Score: 0.011
  32. Shaw JO, Henson PM. The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets. Am J Pathol. 1980 Mar; 98(3):791-810.
    View in: PubMed
    Score: 0.011
  33. Hellewell PG, Henson PM, Downey GP, Worthen GS. Control of local blood flow in pulmonary inflammation: role for neutrophils, PAF, and thromboxane. J Appl Physiol (1985). 1991 Mar; 70(3):1184-93.
    View in: PubMed
    Score: 0.006
  34. Alonso F, Henson PM, Leslie CC. A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine. Biochim Biophys Acta. 1986 Sep 12; 878(2):273-80.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)